Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQXT.L Regulatory News (QXT)

  • There is currently no data for QXT

Director Shareholding

13 Oct 2020 07:00

RNS Number : 8508B
Quixant PLC
13 October 2020
 

 

13 October 2020

Quixant plc

("Quixant" or the "Company" or the "Group")

 

Director Shareholding

 

Quixant (AIM: QXT), a leading provider of specialised computing platforms and monitors for gaming and slot machine applications, announces that it was informed on 12 October 2020 that Jon Jayal, Chief Executive Officer purchased 4,191 ordinary shares of 0.1p each ("Ordinary Shares") at a price of 119.00 pence per Ordinary Share and 4,156 Ordinary Shares at a price of 120.00 pence per Ordinary Share (the "Purchases").

Following the Purchases, Jon Jayal is beneficially interested in 383,547 Ordinary Shares, representing approximately 0.58 per cent. of the Company's issued share capital.

The below notification, made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail on the transactions.

 

Quixant plc

Tel: +44 (0)1223 892 696

Jon Jayal, Chief Executive Officer

Andrew Jarvis, Interim Chief Financial Officer

Nominated Adviser and Broker:

finnCap Ltd

Tel: +44(0)20 7220 0500

Matt Goode / Simon Hicks (Corporate Finance)

Alice Lane (Corporate Broking)

Financial PR:

Tel: +44 (0) 20 3405 0205

Alma PR

John Coles / Susie Hudson / David Ison / Kieran Breheny

 

About Quixant

 

Quixant, founded in 2005, was established as a designer and manufacturer of highly optimised computing and display solutions for the global gaming industry. Through the acquisition of Densitron Technologies plc in 2015, the Company diversified into other markets and has a focused technology offering for the broadcast sector, leveraging the business' extensive sector knowledge across many industries.

 

The Company is headquartered in Cambridge in the UK, with a global customer base and offices in North America, Europe and Asia. The Taiwanese operation is responsible for design, procurement and manufacturing of the Company's products. Quixant owns all its IP, some of which is protected by patents and design rights.

 

In-depth information on the Company's products, markets, activities and history can be found on the corporate website at www.quixant.com.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Jon Jayal

2.

Reason for the notification

a)

Position/status:

CEO

b)

Initial notification/Amendment:

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Quixant plc

 

b)

LEI:

2138003VERSWQP561X71

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary shares of 0.1p

 

GB00B99PCP71

b)

Nature of the transaction:

Purchase of ordinary shares of 0.1p

 

c)

Price(s) and volume(s):

Price(s)

Volume(s)

119.0p

4,191

120.0p

4,156

d)

Aggregated information:

· Aggregated volume:

· Price:

Purchase of 8,347 ordinary shares at an average price of 119.5p per ordinary share

e)

Date of the transaction:

12 October 2020

 

f)

Place of the transaction:

Off market transaction

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHKKBBDFBDDQKD
Date   Source Headline
10th Dec 20209:00 amRNSPrice Monitoring Extension
10th Dec 20207:00 amRNSTrading Update
17th Nov 20205:52 pmRNSHolding(s) in Company
27th Oct 20207:00 amRNSExercise of Options
14th Oct 20206:15 pmRNSHolding(s) in Company
13th Oct 20207:00 amRNSDirector Shareholding
12th Oct 20203:17 pmRNSGrant of Options
7th Oct 20205:26 pmRNSHolding(s) in Company
30th Sep 20207:00 amRNSInterim Results
19th Aug 20207:00 amRNSAppointment of Interim CFO
10th Aug 20207:00 amRNSChanges to the Board of Directors
23rd Jul 20204:45 pmRNSHolding(s) in Company
23rd Jul 20204:05 pmRNSHolding(s) in Company
22nd Jul 20207:00 amRNSTrading Update and Notice of Results
3rd Jul 20205:57 pmRNSHolding(s) in Company
3rd Jul 20205:57 pmRNSHolding(s) in Company
19th May 20204:21 pmRNSResult of AGM
19th May 20207:00 amRNSTrading Update
6th May 20204:41 pmRNSSecond Price Monitoring Extn
6th May 20204:35 pmRNSPrice Monitoring Extension
29th Apr 20204:42 pmRNSSecond Price Monitoring Extn
29th Apr 20204:36 pmRNSPrice Monitoring Extension
28th Apr 20207:00 amRNSDirector/PDMR Shareholding
27th Apr 20207:00 amRNSDesignate Director Shareholding
23rd Apr 20207:00 amRNSAppointment of Non-Executive Director
6th Apr 20207:00 amRNSAudited Final Results
3rd Apr 202012:23 pmRNSHolding(s) in Company
31st Mar 20207:00 amRNS2019 Trading and COVID-19 update
27th Mar 20203:08 pmRNSTiming of Results
26th Mar 20204:50 pmRNSBoard Change
19th Mar 202012:50 pmRNSHolding(s) in Company
18th Mar 20207:00 amRNSNotice of Results Update
12th Feb 20205:44 pmRNSHolding(s) in Company
29th Jan 20207:00 amRNSTrading Update and Notice of Results
20th Dec 20195:50 pmRNSHolding(s) in Company
24th Oct 20194:13 pmRNSDirector/PDMR Shareholding
22nd Oct 20193:05 pmRNSHolding(s) in Company
22nd Oct 20193:05 pmRNSHolding(s) in Company
14th Oct 20194:10 pmRNSDirector/PDMR Shareholding
7th Oct 20195:14 pmRNSDirector/PDMR Transfer Shareholding
27th Sep 20193:41 pmRNSHolding(s) in Company
23rd Sep 20193:09 pmRNSDirector/PDMR Shareholding
19th Sep 20194:13 pmRNSDirector/PDMR Shareholding
18th Sep 20194:54 pmRNSDirector/PDMR Shareholding
17th Sep 20199:05 amRNSSecond Price Monitoring Extn
17th Sep 20199:00 amRNSPrice Monitoring Extension
17th Sep 20197:00 amRNSInterim Results
23rd Jul 20197:00 amRNSTrading Update and Notice of Results
22nd Jul 201911:54 amRNSExercise of Options
4th Jul 20197:00 amRNSCompany Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.